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Our studies show that HIV-1, HIV-2, and HTLV-I infection
all provoke a progressive defect in surface T cell receptor
expression. A specific loss of CD3γ transcripts is responsi-
ble for the defect after HIV-1 or HIV-2 infection. Alterna-
tively, while CD3γ transcripts are lost first after HTLV-I
infection, their reduction is followed several months later
by a loss of CD3δ and subsequently CD3ε mRNA. Studies
of CD3γ transcriptional control revealed parallels with
elements regulating HIV-1 gene expression, including a
downstream element reminiscent of HIV TAR. Mutant
and deletion CD3γ promoter constructs delimited a 53 bp
region downstream from the major transcription start site
as critical for positive gene expression. EMSA experiments
demonstrate that this sequence functions through an RNA
rather than a DNA intermediate, which can bind three
specific nuclear protein complexes. Deletion of U at +9
and +37 kills promoter activity. Alternatively, progressive
silencing of the CD3 gene locus by HTLV-I functions via
chromatin remodeling, characterized by increased bind-
ing of Ikaros to the CD3 γ promoter and the CD3δ
enhancer. Expression of the CD3 genes can be reactivated
in HTLV-I infected cells by the synergistic action of the his-
tone deactylase inhibitor trichostatin A and the DNA
methyltransferase inhibitor 5-aza-2'-deoxycytidine. The
importance of viral targeting of the CD3 genes will be dis-
cussed.
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